ELACESTRANT in Women and Men With CDK4/6 Inhibitor-Naive Estrogen Receptor Positive, HER-2 Negative Metastatic Breast Cancer Study
Clinical trial NCT05596409 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05596409
- Sponsor
- Stemline Therapeutics, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-05-19
- Primary completion
- 2026-11-01
- Enrollment
- 61
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.